Click For Photo: https://3dprintingindustry.com/wp-content/uploads/2018/10/Poietis-bioprinter-NGB-17.03_d.jpg
French biotechnology company Poietis, has announced the launch of a new 4D bioprinting platform. Titled Next Generation Bioprinting (NGB), the technology incorporates automation, robotics and sensors, to improve performance.
It is also to be realized in two new 3D bioprinters from the company: the NGB-R, for research applications, and the NGB-C, to meet future clinical needs of its partners.
Poietis - Bioprinting - Technology - Laser - Process
Poietis’ 4D bioprinting technology is a laser assisted process. In it, a pulsed laser is used to deposit microscopic droplets of cell-laden ink onto a substrate.
The 4D element of technology, as with typical 4D printing, is time – as in the time taken for layered droplets to develop into tissues after 3D bioprinting. By adopting 4D instead of 3D, Poietis differentiates itself from a growing bioprinting market, though time to culture is still required of all current cell-based 3D fabrication techniques.
NGB - Platform - Poietis - Industry - Technologies
With the new NGB platform, Poietis has integrated several Industry 4.0 driven technologies into its 4D bioprinting operations. As such, the platform has been upgraded with features to facilitate automation, the use of robotics, and multiple bioprinting techniques. Numerous online sensors have also been added for process monitoring, including a module for timelapse imaging of cell development at a microscopic level, or “cell microscopy.”
Fabien Guillemot, President and Chief Strategy Officer at Poietis, explains “We have upgraded the NGB platform to an automated robotic system to improve the standardization of manufacturing processes and the functionality of biological tissues.”
Addressing the importance of...
Wake Up To Breaking News!